Published in Cancer Weekly, January 29th, 2002
"This landmark milestone means that we now have our new cell-culture-manufactured OvaRex product available for the first time to take to the clinic for human comparability testing," noted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.